Opcon-A (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Opcon-A drug offered from Bausch & Lomb Incorporated. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
NON-PROPRIETARY NAME: | Naphazoline hydrochloride and Pheniramine maleate |
SUBSTANCE NAME: | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1994-06-08 |
END MARKETING DATE: | 0000-00-00 |
Opcon-A HUMAN OTC DRUG Details:
Item Description | Opcon-A from Bausch & Lomb Incorporated |
LABELER NAME: | Bausch & Lomb Incorporated |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .2675; 3.15(mg/mL; mg/mL) |
START MARKETING DATE: | 1994-06-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 24208-430_94ec6224-2652-4c81-99b5-aab6379e94ad |
PRODUCT NDC: | 24208-430 |
APPLICATION NUMBER: | NDA020065 |
Other NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE Pharmaceutical Manufacturers / Labelers: